Fluorescence in situ hybridisation

HSL-AD is highly experienced in using fluorescence in situ hybridization (FISH) and chromogenic in situ hybridisation (CISH) probes on cancer samples.

These probes can be used to test cancer samples for duplication/amplifications, deletions, and translocations of their genetic material. The results can aid diagnosis, prognosis, predicting response to treatment, and surveillance.

HSL-AD participates in external quality assurance (EQA) across various modules through UK NEQAS ICC & ISH, NordiQC, and GenQA. For tests not covered by conventional EQA schemes within the previous 12 months, an alternative approach to EQA is implemented to ensure ongoing quality assessment.

Please use the search box below to filter this list